Revelation Biosciences Inc.

13F holders, Q1 2025 (March 31)
1holders −8
1new positions
9sold out
$0.24avg. 13F price*

At the end of Q1 2025, 1 institutions reported holding Revelation Biosciences Inc. in their 13F filings, down 8 from Q4 2024. 1 opened new positions and 9 sold out. The largest holder was IFP Advisors, Inc ($954).

Company
Revelation Biosciences Inc.
CUSIP
76135L507
Latest filing quarter
Q1 2025

History

Number of 13F holders

0246810 Q1 2024: 7Q1 2024Q2 2024: 7Q2 2024Q3 2024: 7Q3 2024Q4 2024: 9Q4 2024Q1 2025: 1Q1 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions1$954
Exits9$49K

All 13F filers, Q4 2024 → Q1 2025: 4,000 shares bought and 106,941 shares sold, net −102,941 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

IFP Advisors, Inc 0.00% New 4,000 $954

"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.